Pfizer Hits Alkem, Sandoz With Suits Over Generic Toviaz
Pfizer Inc. hit Alkem Laboratories Ltd. and Sandoz Inc. with lawsuits Friday aimed at blocking their recent bids to launch generic versions of Pfizer's Toviaz, a drug used to treat overactive...To view the full article, register now.
Already a subscriber? Click here to view full article